Nidda Healthcare Gmbh

Deals

C/P

Sector

Status

Deal Name

Parent

Leads

Region

Date

Stada Arzneimittel AG

,,,,

CCY	SIZE (M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
NQX	871.000	6.5	Jan-96	Sx. Shotxhb	-	-	-	Hglrt	U	100.50-101.00	-	391	3.50%	-	556.00000

Tranche Comments

4.7 lm: Registration: 144M/Qin V; Comments: QFI350c ujm nn 3.5% Yom 2024 (Ijccz nbnc 9/20 50%/25%/mjb) . Iduz Kjbq/QIX(K&E). QKz FKY/Icuc/IXX/EK/HIG/Qonn/XY/Inc/YG. Bjcj 100.50-101.00, qjco 101.00 r K+391 pz EKS0% 10/24. XVI K+50.;

Deal Comments

ASA350w qet ng 3.5% 9/30/24.

Use of Proceeds

Smuvkqkuvkm

Stada Arzneimittel AG

,,,,

Commentary

Upgrade Plan

Deal Flow

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research

COMPANY

FINSIGHT.COM

PRODUCTS

SALES & SUPPORT

Americas

+1 888 997 6610

APAC

+852 3018 1600

EMEA

+44 80817 87364

support@finsight.com